報價延遲最少15分鐘:2025/09/16 21:50 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.31 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.12/-0.30
|
|
企業價值
47.28M
|
| 資產負債 |
|
每股賬面淨值
0.91
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
14.16M
|
|
每股收益
1.15
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/09/16 21:50 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. Incommercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues. |
